Implantable Pulmonary Artery Sensors: What Nurses Need to Know

Author(s): Velasco Juvel-Lou P

Contact Hours 1.20

CERP A 1.20

Expires Dec 31, 2026

Topics: Hemodynamics, Technology

Population: Adult

Role: Staff

Fees
Member: Free
NonMember: $10.00

Added to Collection

Activity Summary

Required reading for all learners: Implicit Bias impacts patient outcomes

The implantable pulmonary artery (PAP) sensor represents an innovative technology that enables healthcare providers to directly and remotely monitor intracardiac pressures. There is a growing body of evidence supporting the efficacy of pulmonary artery pressure sensor devices in preventing and reducing heart failure readmissions. As of January 2021, more 20,000 patients have received this implantable device. With the recent approval from the Food and Drug Administration to expand the device’s indications in March 2022, it is anticipated that the rate of implantation will double. Therefore, it is crucial for nurses to gain expertise in caring for patients implanted with this device.

Objectives

  • Review normal intracardiac pressures and their surrogate values.
  • Identify the criteria for eligibility for implantable pulmonary artery pressure sensors.
  • Describe the care involved during the screening phase, the implantation phase and the optimization/maintenance phase.

Continuing Education Disclosure Statement

Successful Completion

Learners must complete the entire activity and the associated evaluation to be awarded contact hours AND read Implicit Bias impacts patient outcomes. No partial credit will be awarded.

Accreditation

The American Association of Critical-Care Nurses is accredited as a provider of nursing continuing professional development by the American Nurses Credentialing Center's Commission on Accreditation.
Provider approved by the California Board of Registered Nursing, Provider number CEP 1036, for {contactHours} contact hours.

Disclosures

Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content will be identified by the Nurse Planner within the activity. Any relevant relationship between an ineligible company and an individual with the ability to influence clinical content has been mitigated.

Accreditation refers to recognition of continuing education only and does not imply AACN, ANCC, or CBRN approval or endorsement of any commercial products discussed or displayed in conjunction with this educational activity. Activities with pharmacology hours are to assist the APRN in fulfilling the pharmacotherapeutic education requirements for licensure and certification renewals.

Activities meet the standards for most states that require mandatory continuing education for license and/or certification renewal. AACN recommends consulting with your own state board of nursing or credentialing organization before submitting your certificate of completion.

Refund Policy

Continuing Education Activities are nonrefundable.